000 | 01560cam a22003734a 4500 | ||
---|---|---|---|
001 | 11812940 | ||
005 | 20160728100741.0 | ||
008 | 990928s2000 nyua b 001 0 eng c | ||
010 | _a 99049549 | ||
020 | _a082478216X (alk. paper) | ||
035 | _a(DNLM)100896988 | ||
040 |
_aDNLM/DLC _cDLC _dDLC |
||
042 | _apcc | ||
050 | 0 | 0 |
_aRC632.H83 _bC475 2000 |
060 | 1 | 0 |
_aWD 200.5.H8 _bC54727 2000 |
082 | 0 | 0 |
_a616.1/3606 _221 |
245 | 0 | 0 |
_aCholesterol-lowering therapy : _bevaluation of clinical trial evidence / _cedited by Scott M. Grundy. |
260 |
_aNew York : _bMarcel Dekker, _cc2000. |
||
300 |
_axv, 329 p. : _bill. ; _c24 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
650 | 0 |
_aAnticholesteremic agents _xTesting. _956348 |
|
650 | 0 |
_aHypercholesteremia _xChemotherapy. _956349 |
|
650 | 1 | 2 |
_aHypercholesterolemia _xcomplications. _956350 |
650 | 1 | 2 |
_aHypercholesterolemia _xdiet therapy. _956351 |
650 | 1 | 2 |
_aHypercholesterolemia _xdrug therapy. _956352 |
650 | 2 | 2 |
_aClinical Trials _xhistory. _956353 |
650 | 2 | 2 |
_aCoronary Disease _xetiology. _956354 |
650 | 2 | 2 |
_aCoronary Disease _xprevention & control. _931137 |
700 | 1 |
_aGrundy, Scott M. _956355 |
|
856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0648/99049549-d.html |
906 |
_a7 _bcbc _corignew _d1 _eocip _f19 _gy-gencatlg |
||
942 |
_2lcc _cBK |
||
999 |
_c25235 _d25235 |